Absence of left ventricular hypertrophy in severe isolated aortic stenosis and preserved left ventricular systolic

Insights

In severe aortic stenosis (AS), left ventricular hypertrophy (LVH) is not always present and does not worsen outcomes. Normal left ventricular geometry is linked to better survival, independent of LVH.

Area of Science:

  • Cardiology
  • Echocardiography
  • Clinical Medicine

Background:

  • Severe aortic stenosis (AS) traditionally assumes left ventricular hypertrophy (LVH) is necessary for preserving systolic function.
  • Recent evidence suggests this paradigm may not hold true for all patients.

Purpose of the Study:

  • To investigate the clinical, echocardiographic, and prognostic significance of absent LVH in patients with symptomatic severe AS and preserved left ventricular ejection fraction (LVEF).
  • To determine if LVH impacts outcomes in this specific patient population.

Main Methods:

  • Analysis of echocardiographic, clinical, and survival data from 512 patients with severe AS and preserved LVEF.
  • Classification of patients based on the presence or absence of LVH using American Society of Echocardiography criteria.
  • Follow-up for all-cause mortality and aortic valve replacement (AVR) events.

Main Results:

  • LVH was absent in 36% of patients with severe AS and preserved LVEF.
  • Patients without LVH had distinct demographic and echocardiographic characteristics, including larger body surface area and aortic valve area index.
  • No significant association was found between left ventricular mass index (LVMi) as a continuous variable and survival.
  • A normal left ventricular geometry, not just the absence of LVH, was associated with a survival benefit.

Conclusions:

  • Left ventricular hypertrophy is not a universal finding in severe AS with preserved LVEF and does not appear to be associated with worse outcomes.
  • Normal left ventricular geometry, rather than LVH status, is a significant predictor of lower mortality.
  • Aortic valve replacement (AVR) improves survival irrespective of LVMi, suggesting alternative mechanisms to hypertrophy can mitigate AS afterload effects.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K